Skip to main content

Kaspersky statement on compliance in the U.S. following ICTS Final Determination

July 18, 2024

In conformity with the Final Determination by the U.S. Department of Commerce, Kaspersky announces it has stopped sales contracts of its anti-virus software and cybersecurity products in the United States ahead of July 20, 2024. Starting from September 30, 2024, Kaspersky will be prohibited from providing anti-virus signature updates and codebase updates to U.S. consumers and businesses. Until then, the company will continue fulfilling its obligations under all existing contracts. Starting from July 20, 2024 Kaspersky will also gradually wind down its U.S. operations and eliminate U.S.-based positions.

Kaspersky has been fully committed to transparency and providing high-quality protection against any type of threat. To respond to the U.S. authorities’ concerns, the company has proposed a comprehensive assessment framework providing for the verification of its solutions, database updates, threat detection rules by an independent trusted reviewer. Therefore, Kaspersky maintains that the U.S. Department of Commerce decision was based on the geopolitical climate rather than on the evaluation of the integrity of the company’s solutions and deprives U.S. users and companies of best in class protection.

Kaspersky’s informational or educational products and services such as Kaspersky Threat Intelligence and Kaspersky Cybersecurity Training, as well as Kaspersky consulting or advisory services (including SOC Consulting, Security Consulting, Ask the Analyst, and Incident Response) will continue to be available in the U.S. market.

Kaspersky remains strong in its ongoing support for its customers and partners worldwide providing leading cybersecurity solutions. The company stays dedicated to delivering top-tier cybersecurity technologies, recognized for their excellence through numerous independent awards and third-party audits. Kaspersky will continue to deliver on its mission of building a safer world.


Kaspersky statement on compliance in the U.S. following ICTS Final Determination

In conformity with the Final Determination by the U.S. Department of Commerce, Kaspersky announces it has stopped sales contracts of its anti-virus software and cybersecurity products in the United States ahead of July 20, 2024. Starting from September 30, 2024, Kaspersky will be prohibited from providing anti-virus signature updates and codebase updates to U.S. consumers and businesses. Until then, the company will continue fulfilling its obligations under all existing contracts. Starting from July 20, 2024 Kaspersky will also gradually wind down its U.S. operations and eliminate U.S.-based positions.
Kaspersky logo

About Kaspersky

Kaspersky is a global cybersecurity and digital privacy company founded in 1997. Innovating the industry with a Cyber Immunity approach, Kaspersky safeguards consumers, businesses, critical infrastructure, and governments from cyberthreats, with over a billion devices protected to date.

Kaspersky ensures Cybersecurity True to Business, focusing on providing clear outcomes, protecting revenue, easing workloads and preventing downtime. Kaspersky’s deep threat intelligence and security expertise is constantly transforming into innovative solutions and services for organizations of every size, from small businesses to large enterprises, combining proven AI-driven protection technologies with simple management and expert support.

Recognized in independent tests and trusted by millions of individuals worldwide and nearly 200,000 organizations, Kaspersky helps detect threats earlier, respond faster and operate with greater confidence and freedom, protecting what matters most to our clients. Learn more at www.kaspersky.com.

Related Articles Press Releases